» Articles » PMID: 37809421

Breast Cancer Stem Cells Tolerate Chromosomal Instability During Tumor Progression Via C-Jun/AXL Stress Signaling

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Oct 9
PMID 37809421
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosomal instability (CIN) is critical for tumor evolution, yet its relationship with stemness is unclear. Here, we describe CIN as a key stress induced during tumor initiation that is uniquely tolerated by breast cancer stem cells in an activated signaling state (aCSCs). While we noted elevated CIN specifically in tumors from aCSCs, this was not intrinsic to these cells, as baseline levels were similar to non-stem cell types. This suggests that CIN is induced during tumor initiation, and that aCSCs can better tolerate this stress. Further, this increased CIN may be transient, as it was only in low-burden aCSC tumors, with levels diminishing in more established disease. Phospho-array profiling revealed specific activation of c-Jun stress signaling in aCSCs, which we hypothesized could induce genes responsible for CIN tolerance. Indeed, we identified as a c-Jun dependent gene enriched in aCSCs that enhances resistance to this stress. Thus, CIN tolerance mediated by c-Jun/AXL signaling may be a defining feature of stemness, contributing to breast cancer progression.

Citing Articles

Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?.

Malikova I, Worth A, Aliyeva D, Khassenova M, Kriajevska M, Tulchinsky E Cell Death Dis. 2025; 16(1):155.

PMID: 40044635 PMC: 11883011. DOI: 10.1038/s41419-025-07480-9.


Chromosomal instability as an architect of the cancer stemness landscape.

Baba S, Zakeri A, Desgrosellier J Front Cell Dev Biol. 2024; 12:1450614.

PMID: 39345336 PMC: 11427409. DOI: 10.3389/fcell.2024.1450614.


Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential.

Chamorro D, Somes L, Hoyos V Cancers (Basel). 2024; 16(1).

PMID: 38201551 PMC: 10778447. DOI: 10.3390/cancers16010124.

References
1.
Behrens A, Sibilia M, Wagner E . Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet. 1999; 21(3):326-9. DOI: 10.1038/6854. View

2.
Munoz R, Man S, Shaked Y, Lee C, Wong J, Francia G . Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer Res. 2006; 66(7):3386-91. DOI: 10.1158/0008-5472.CAN-05-4411. View

3.
Gjerdrum C, Tiron C, Hoiby T, Stefansson I, Haugen H, Sandal T . Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci U S A. 2010; 107(3):1124-9. PMC: 2824310. DOI: 10.1073/pnas.0909333107. View

4.
Asiedu M, Beauchamp-Perez F, Ingle J, Behrens M, Radisky D, Knutson K . AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells. Oncogene. 2013; 33(10):1316-24. PMC: 3994701. DOI: 10.1038/onc.2013.57. View

5.
Lim E, Vaillant F, Wu D, Forrest N, Pal B, Hart A . Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009; 15(8):907-13. DOI: 10.1038/nm.2000. View